middle.news
Island Pharmaceuticals Advances Galidesivir Antiviral with Government Approvals and Clinical Data Plans Amid Urgent Ebola Outbreak
10:02am on Wednesday 8th of July, 2026 AEST
•
Healthcare
Read Story
Island Pharmaceuticals Advances Galidesivir Antiviral with Government Approvals and Clinical Data Plans Amid Urgent Ebola Outbreak
10:02am on Wednesday 8th of July, 2026 AEST
Key Points
Galidesivir targets multiple filoviruses including Ebola, Marburg, Sudan
Government approvals secured for compassionate use in Uganda under WHO MEURI
Strong efficacy demonstrated in non-human primate models with delayed dosing
Dual regulatory pathway combining human outbreak data and FDA Animal Rule studies
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE